Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
2.150
+0.040 (1.90%)
Sep 16, 2026, 3:04 PM EDT - Market open
Valion Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.11 | 12.65 | 2 | 3.4 | 3.52 | 12.98 |
Cash & Short-Term Investments | 2.11 | 12.65 | 2 | 3.4 | 3.52 | 12.98 |
Cash Growth | 78.04% | 531.62% | -41.03% | -3.47% | -72.89% | 1142.82% |
Receivables | - | - | - | 0.17 | 0.11 | 0.09 |
Inventory | 0.75 | - | - | 0.76 | 0.86 | 0.43 |
Prepaid Expenses | 0.33 | 0.35 | 0.24 | 0.33 | 0.24 | 0.79 |
Other Current Assets | 0.19 | 0.02 | 0.4 | - | 0.58 | - |
Total Current Assets | 3.38 | 13.01 | 2.64 | 4.65 | 5.31 | 14.29 |
Property, Plant & Equipment | 22.18 | 12.64 | 0 | 0.47 | 0.54 | 0.7 |
Goodwill | 3.46 | 3.46 | - | - | - | - |
Other Intangible Assets | 2.24 | 2.24 | - | - | - | - |
Long-Term Deferred Charges | 0.63 | 0.14 | 0.05 | - | - | - |
Other Long-Term Assets | 0.58 | 0.12 | 0.12 | 0.03 | 0.03 | 0.05 |
Total Assets | 32.47 | 31.61 | 2.81 | 5.16 | 5.88 | 15.04 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.64 | 0.26 | 0.13 | 0.71 | 1.32 | 0.79 |
Accrued Expenses | 1.83 | 0.38 | 0.13 | 0.49 | 0.39 | 0.25 |
Current Portion of Leases | 0.53 | - | - | 0.19 | 0.16 | 0.16 |
Current Unearned Revenue | - | - | - | 0.01 | 0 | 0.02 |
Other Current Liabilities | 0.04 | 0.01 | 0.02 | - | - | - |
Total Current Liabilities | 3.05 | 0.65 | 0.27 | 1.4 | 1.88 | 1.22 |
Long-Term Debt | 7.39 | 6.45 | - | - | - | - |
Long-Term Leases | 9.49 | - | - | 0.18 | 0.37 | 0.55 |
Other Long-Term Liabilities | 8.31 | 7.71 | - | - | - | - |
Total Liabilities | 28.23 | 14.81 | 0.27 | 1.58 | 2.25 | 1.76 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | - | - | 0 |
Additional Paid-In Capital | 70.75 | 69.39 | 46.08 | 41.47 | 33.27 | 32.82 |
Retained Earnings | -66.51 | -52.6 | -43.54 | -37.89 | -29.64 | -19.55 |
Total Common Equity | 4.25 | 16.8 | 2.54 | 3.58 | 3.63 | 13.27 |
Shareholders' Equity | 4.25 | 16.8 | 2.54 | 3.58 | 3.63 | 13.27 |
Total Liabilities & Equity | 32.47 | 31.61 | 2.81 | 5.16 | 5.88 | 15.04 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 17.41 | 6.45 | - | 0.37 | 0.53 | 0.71 |
Net Cash (Debt) | -15.3 | 6.19 | 2 | 3.03 | 2.99 | 12.27 |
Net Cash Growth | - | 209.24% | -33.84% | 1.31% | -75.65% | 1311.62% |
Net Cash Per Share | -167.25 | 133.94 | 174.16 | - | - | - |
Filing Date Shares Outstanding | 0.89 | 0.12 | 0.02 | - | - | - |
Total Common Shares Outstanding | 0.17 | 0.1 | 0.02 | - | - | - |
Working Capital | 0.34 | 12.36 | 2.37 | 3.25 | 3.43 | 13.07 |
Book Value Per Share | 25.57 | 166.26 | 113.78 | - | - | - |
Tangible Book Value | -1.45 | 11.1 | 2.54 | 3.58 | 3.63 | 13.27 |
Tangible Book Value Per Share | -8.75 | 109.84 | 113.78 | - | - | - |
Machinery | 12.72 | 12.66 | 0.04 | 0.16 | 0.04 | - |